National Institute for Pharmaceutical Technology & Education (NIPTE)

Corning Reports Fourth-Quarter and Full-Year 2022 Financial Results

Retrieved on: 
Tuesday, January 31, 2023
Semiconductor, Professional corporation, Science, GAAP, Optics, Wendell Weeks, Legislation, NYSE, Commerce, Gasoline, Corning Inc., EPS, Advanced Optical Materials, Carbon, History, GLW, Device file, Science and technology in Asia, National Institute for Pharmaceutical Technology & Education (NIPTE), Nokia, LG Electronics, Veteran, Television, GPF, Inclusion, Samsung, Smartphone, AT, Communes of Burundi, Hemlock, Glass, Engineering, AT&T, Video game, Renewable energy, United, Corning, Galaxy

CORNING, N.Y., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Corning Incorporated (NYSE: GLW) today announced its fourth-quarter and full-year 2022 results and provided its outlook for first-quarter 2023.

Key Points: 
  • CORNING, N.Y., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Corning Incorporated (NYSE: GLW) today announced its fourth-quarter and full-year 2022 results and provided its outlook for first-quarter 2023.
  • Display Technologies maintained stable pricing year over year despite a sharp drop in panel maker utilization in the second half.
  • Management took actions to increase price and improve productivity in the fourth quarter of 2022.
  • We remain confident in our ability to deliver durable multiyear growth.”
    Ed Schlesinger, executive vice president and chief financial officer, said: “In 2022, we grew full-year sales and EPS.

Allied Electronics & Automation Announces Ready-to-Ship Solutions for Medical Industry Applications

Retrieved on: 
Wednesday, January 4, 2023
National Institute for Pharmaceutical Technology & Education (NIPTE), ISO 9001:2015, Robotics, Oxygen, Gunnar B. Stickler, Dialysis, Social media, HFO, Solvent, HFC, London, HID, HFE, FDA, Safety, RS Group, RS1, LSE, R, Microcar (brand), LED, RS, Automation, Medicine, Electronics, Gas, Research, ISO, Maintenance, TCP, London Stock Exchange, Oil, Medical device

FORT WORTH, Texas, Jan. 4, 2023 /PRNewswire/ -- Allied Electronics & Automation, a trading brand of RS Group plc (LSE: RS1), a global omni-channel provider of product and service solutions, announces ready-to-ship solutions for medical industry applications from ABB Robotics, Bürkert Fluid Control Systems, Keystone Technologies, and MicroCare.

Key Points: 
  • FORT WORTH, Texas, Jan. 4, 2023 /PRNewswire/ -- Allied Electronics & Automation , a trading brand of RS Group plc (LSE: RS1), a global omni-channel provider of product and service solutions, announces ready-to-ship solutions for medical industry applications from ABB Robotics, Bürkert Fluid Control Systems, Keystone Technologies, and MicroCare.
  • Medical industry applications include improving assembly and production efficiencies and assisting with lab testing procedures.
  • For assistance identifying and deploying products engineered for use in medical industry applications, please contact your local Allied representative at 1.866.433.5722 or reach out to Allied's technical support team .
  • For more information about Allied Electronics & Automation, please visit www.alliedelec.com/ or connect with us via social media on Facebook , Twitter , and LinkedIn .

NATERA 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Natera, Inc. - NTRA

Retrieved on: 
Saturday, June 25, 2022
Class Action Lawsuit, Professional Services, Legal, NTRA, Patient, Court, Special warfare combatant-craft crewmen, Marketing, District court, Company, Nasdaq, Lists of schools in England, KSF, Oportunidades, National Institute for Pharmaceutical Technology & Education (NIPTE), LLC, Communication, Safety, News, Online gambling, Natera, Panorama

This action is pending in the United States District Court for the Western District of Texas.

Key Points: 
  • This action is pending in the United States District Court for the Western District of Texas.
  • Natera and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
  • On this news, shares of Natera fell $8.81, or 22.5% to close at $30.32 per share on March 15, 2022.
  • About Kahn Swick & Foti, LLC
    KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nations premier boutique securities litigation law firms.

NATERA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Natera, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, June 25, 2022
Legal, Professional Services, Complaint, Insurance, FDA, NTRA, Patient, Campaign, Lists of diseases, Court, P.C, Marketing, Growth, Company, District court, Jeanne Eagels, Hindenburg Research, Telephone, Genetic testing, Lists of schools in England, Oportunidades, National Institute for Pharmaceutical Technology & Education (NIPTE), NIPT, Person, Communication, Panorama, SEC, Chromosome, NASDAQ, Time, Safety, News, The New York Times, Fetus, Pharmaceutical industry, Renewable energy, Natera

Investors have until June 27, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until June 27, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Natera, a Delaware corporation with principal executive offices in Austin, Texas, offers genetic testing in the areas of womens health, oncology, and organ health.
  • Among other things, the Company produces and markets a non-invasive prenatal test (NIPT) called Panorama, and a screening test for kidney transplant failure called Prospera.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

NATERA, INC. (NASDAQ: NTRA) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Natera, Inc. (NASDAQ: NTRA)

Retrieved on: 
Wednesday, June 22, 2022
Hindenburg Research, Time, Securities Exchange Act of 1934, FDA, NEW, Safety, Company, Lists of schools in England, National Institute for Pharmaceutical Technology & Education (NIPTE), Court, Lists of diseases, Insurance, Accountability, Growth, The Legal 500, Lists of action films, The New York Times, Labour government, Marketing, Advertising, GLOBE, Investment, District court, NASDAQ, News, SEC, Oportunidades, Campaign, NTRA, Patient, Communication, Genetic testing, Panorama, Fetus, Tobacco, Pharmaceutical industry, Online gambling, Security (finance), Natera

NEW YORK, June 22, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the common stock of Natera, Inc. (“Natera” or the “Company”) (NASDAQ: NTRA) between February 26, 2020 and April 19, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Western District of Texas and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • The lawsuit was filed in the United States District Court for the Western District of Texas and alleges violations of the Securities Exchange Act of 1934.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

NATERA SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Natera, Inc. - NTRA

Retrieved on: 
Wednesday, June 22, 2022
Safety, Lists of schools in England, National Institute for Pharmaceutical Technology & Education (NIPTE), Company, LLC, Lawyer, Marketing, GLOBE, FREE, District court, News, Oportunidades, NTRA, Patient, Communication, Nasdaq, Online gambling, Natera, Panorama

This action is pending in the United States District Court for the Western District of Texas.

Key Points: 
  • This action is pending in the United States District Court for the Western District of Texas.
  • Natera investors should visit us at https://claimsfiler.com/cases/nasdaq-ntra-1/ or call toll-free (844) 367-9658.
  • Natera and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
  • On this news, shares of Natera fell $8.81, or 22.5% to close at $30.32 per share on March 15, 2022.

NATERA, INC. (NASDAQ: NTRA) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Natera, Inc. (NASDAQ: NTRA)

Retrieved on: 
Wednesday, June 15, 2022
Hindenburg Research, Time, Securities Exchange Act of 1934, FDA, NEW, Safety, Company, Lists of schools in England, National Institute for Pharmaceutical Technology & Education (NIPTE), Court, Lists of diseases, Insurance, Accountability, Growth, The Legal 500, Lists of action films, The New York Times, Labour government, Marketing, Advertising, GLOBE, Investment, District court, NASDAQ, News, SEC, Oportunidades, Campaign, NTRA, Patient, Communication, Genetic testing, Panorama, Fetus, Tobacco, Pharmaceutical industry, Online gambling, Security (finance), Natera

NEW YORK, June 15, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the common stock of Natera, Inc. (“Natera” or the “Company”) (NASDAQ: NTRA) between February 26, 2020 and April 19, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Western District of Texas and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • The lawsuit was filed in the United States District Court for the Western District of Texas and alleges violations of the Securities Exchange Act of 1934.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

NATERA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Natera, Inc. - NTRA

Retrieved on: 
Wednesday, June 15, 2022
Safety, Lists of schools in England, National Institute for Pharmaceutical Technology & Education (NIPTE), Court, Company, LLC, KSF, Marketing, GLOBE, District court, News, Oportunidades, NTRA, Patient, Communication, Nasdaq, Online gambling, Natera, Panorama

This action is pending in the United States District Court for the Western District of Texas.

Key Points: 
  • This action is pending in the United States District Court for the Western District of Texas.
  • If you wish to serve as a lead plaintiff in this class action, you must petition the Court by June 27, 2022.
  • Natera and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
  • On this news, shares of Natera fell $8.81, or 22.5% to close at $30.32 per share on March 15, 2022.

NATERA, INC. (NASDAQ: NTRA) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Natera, Inc. (NASDAQ: NTRA)

Retrieved on: 
Wednesday, June 8, 2022
Lists of action films, District court, Accountability, Time, Company, Lists of diseases, Insurance, Marketing, Securities Exchange Act of 1934, Campaign, National Institute for Pharmaceutical Technology & Education (NIPTE), Court, NTRA, News, The Legal 500, Investment, The New York Times, FDA, Growth, GLOBE, Patient, Advertising, Genetic testing, Fetus, Hindenburg Research, Labour government, Oportunidades, NASDAQ, SEC, NEW, Panorama, Lists of schools in England, Communication, Safety, Tobacco, Pharmaceutical industry, Online gambling, Security (finance), Natera

NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the common stock of Natera, Inc. (“Natera” or the “Company”) (NASDAQ: NTRA) between February 26, 2020 and April 19, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Western District of Texas and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • The lawsuit was filed in the United States District Court for the Western District of Texas and alleges violations of the Securities Exchange Act of 1934.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

NATERA SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Natera, Inc. - NTRA

Retrieved on: 
Wednesday, June 8, 2022
District court, Company, Marketing, LLC, National Institute for Pharmaceutical Technology & Education (NIPTE), NTRA, News, FREE, GLOBE, Patient, Nasdaq, Lawyer, Oportunidades, Lists of schools in England, Communication, Safety, Online gambling, Natera, Panorama

This action is pending in the United States District Court for the Western District of Texas.

Key Points: 
  • This action is pending in the United States District Court for the Western District of Texas.
  • Natera investors should visit us at https://claimsfiler.com/cases/nasdaq-ntra-1/ or call toll-free (844) 367-9658.
  • Natera and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
  • On this news, shares of Natera fell $8.81, or 22.5% to close at $30.32 per share on March 15, 2022.